A multicenter, multinational, open-label study of the efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive paediatric subjects 6 to less than 17 years of age
Phase of Trial: Phase III
Latest Information Update: 17 Dec 2007
At a glance
- Drugs Candesartan cilexetil (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- 17 Dec 2007 Status changed from in progress to completed.
- 14 Nov 2005 New trial record.